DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II Prevention Trial

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis Eshun, Andre Bachmann, Debra Pankiewicz, Monique Quinn, Jacqueline M. Kraveka. DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II Prevention Trial, Advances in Neuroblastoma Research (ANR), June 2016, Cairns, Australia